ViTToria Biotherapeutics, Inc. — Form D
ViTToria Biotherapeutics, Inc. of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2021-12-30. The offering totals $9.2M, of which $8.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-12-30
- Form: D
- Accession: 0001878646-21-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $9.2M
- Amount sold: $8.7M
- Remaining: $577K
- Investors: 11
- Date of first sale: 2021-07-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-427409
Issuer
- Name: ViTToria Biotherapeutics, Inc.
- CIK: 0001877792
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 3675 MARKET STREET, PHILADELPHIA, PA, 19104
- Phone: 215-981-4000
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Leon Moulder | Director | Woburn, MA |
| Bruce Peacock | Director | Philadelphia, PA |
| Nicholas Siciliano | Director | Marlton, NJ |
| Geeta Vemuri | Director | Waltham, MA |
| Preston Noon | Executive Officer | Philadelphia, PA |
| Bruce Peacock | Executive Officer | Philadelphia, PA |
| Geeta Vemuri | Executive Officer | Waltham, MA |
More